Nov 2NuvOx Announces Contract to Support NOVEL TrialTucson, AZ, USA, October 31, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic...
Oct 2NuvOx Therapeutics Wins Most Fundable Company by Pepperdine Graziadio Business SchoolTucson, AZ, September 28th, 2023 NuvOx Therapeutics (“NuvOx”) is delighted to announce that it achieved the Gold Level recognition on the...
Sep 25NuvOx Closed Oversubscribed Convertible NotesTucson, AZ, September 18th, 2023 NuvOx Therapeutics (“NuvOx”) announced that it has closed an oversubscribed convertible notes round,...
Aug 30NuvOx Announces Publication of Research Article in Cancer Research CommunicationTucson, AZ, August 28th, 2023 NuvOx Pharma announced publication of a research article, “Dodecafluoropentane Emulsion as a...
Aug 14NuvOx Announces BARDA Partnership for a Phase Ib ARDS/COVID Trial in CanadaTucson, AZ, August 4th, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to...